ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,161Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 783

$1.41M Total Retail Price of All Prescriptions

Rank: 12 out of 783

660 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 660 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 660 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 10,433 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 535 220 S3 1 2
ALLOPURINOL 515 391 2 31
CIPROFLOXACIN HCL 440 248 3 62
SINGULAIR 419 207 4 90
BUMETANIDE 417 294 5 131
CARVEDILOL 406 242 6 21
LEVOTHYROXINE SODIUM 396 301 7 1
FUROSEMIDE 381 283 8 7
TERAZOSIN HCL 365 272 9 130
FENOFIBRATE 340 249 10 66
METOPROLOL TARTRATE 323 203 11 9
ZETIA 311 151 12 80
MONTELUKAST SODIUM 301 148 13 160
CRESTOR 287 133 14 27
PRAVASTATIN SODIUM 279 180 15 14
ISOSORBIDE MONONITRATE ER 249 203 16 40
SIMVASTATIN 245 213 17 3
GABAPENTIN 227 67 18 15
DILTIAZEM HCL 220 168 19 207
RANITIDINE HCL 220 115 19 44
CLOPIDOGREL 216 161 21 29
WARFARIN SODIUM 212 156 22 10
CYCLOBENZAPRINE HCL 212 99 R 22 63
ULORIC 209 131 24 300
PREDNISONE 200 99 25 36
KLOR-CON M20 200 153 25 48
METFORMIN HCL 186 102 27 8
POTASSIUM CHLORIDE 175 118 28 16
NAMENDA 174 143 29 32
NEXIUM 173 84 30 28
LISINOPRIL 167 81 31 4
OMEPRAZOLE 158 78 32 6
ROPINIROLE HCL 155 101 33 74
FLUCONAZOLE 152 68 34 179
AMLODIPINE BESYLATE 142 80 35 5
PLAVIX 141 95 36 51
TAMSULOSIN HCL 141 91 36 26
CITALOPRAM HBR 127 73 38 19
ZOLPIDEM TARTRATE 124 52 39 23
GEMFIBROZIL 116 103 40 105
TRICOR 115 41 41 134
TRAZODONE HCL 113 41 42 39
BYSTOLIC 112 35 43 99
PANTOPRAZOLE SODIUM 112 86 43 30
SPIRIVA 110 46 45 59
MELOXICAM 105 59 46 37
AMIODARONE HCL 104 88 47 175
LEVOFLOXACIN 103 54 48 75
SERTRALINE HCL 102 72 49 22
ATORVASTATIN CALCIUM 100 50 50 11
AMITRIPTYLINE HCL 99 32 R 51 77
OXYCODONE HCL-ACETAMINOPHEN 97 0 S2 52 86
TRILIPIX 96 53 53 192
CYPROHEPTADINE HCL 96 65 R 53 369
RIVASTIGMINE 93 79 55 249
MECLIZINE HCL 90 68 56 146
CYMBALTA 89 24 57 35
TOBRAMYCIN 88 43 58 329
SULFAMETHOXAZOLE-TRIMETHOPRIM 88 47 58 95
SYNTHROID 88 45 58 47
AZITHROMYCIN 85 45 61 41
PREMARIN 84 46 R 62 176
SYMBICORT 82 25 63 157
RISPERIDONE 80 43 64 67
METOCLOPRAMIDE HCL 78 47 65 121
TRAMADOL HCL 75 25 66 20
METRONIDAZOLE 71 37 67 229
NYSTATIN 70 32 68 106
ONDANSETRON HCL 70 33 68 261
DEXILANT 70 32 68 225
GLIPIZIDE 68 60 71 71
ESTRADIOL 64 14 R 72 204
DICYCLOMINE HCL 63 14 73 200
TERBINAFINE HCL 61 43 74 413
DICLOFENAC SODIUM 60 34 75 139
CHLORZOXAZONE 58 15 R 76 327
CLONIDINE HCL 58 37 76 60
FLUOXETINE HCL 57 27 78 45
PRAMIPEXOLE DIHYDROCHLORIDE 56 38 79 147
LEVETIRACETAM 56 11 79 89
LANTUS 53 47 81 38
VOLTAREN 52 29 82 251
MEGESTROL ACETATE 52 41 R 82 238
AGGRENOX 51 51 84 196
SUCRALFATE 51 23 84 190
PAROXETINE HCL 51 12 84 69
KLOR-CON M10 50 38 87 137
GLIMEPIRIDE 50 33 87 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.